B2M and cancer: Remarkably, a pan-cancer gene signature for epithelial–mesenchymal plasticity generated in our lab [121] includes genes for HLA-A, -C, and -E, TAP1, PSMB9, and B2M, suggesting that MHC I machinery is, at least in part, associated with the EMT in a variety of cancer cell lines and tumors from different origins.